Mercer Global Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,919
| Closed | -$310K | – | 2182 |
|
|
2024
Q3 | $310K | Sell |
3,919
-2,022
| -34% | -$160K | ﹤0.01% | 1595 |
|
|
2024
Q2 | $491K | Buy |
5,941
+1,718
| +41% | +$142K | ﹤0.01% | 1313 |
|
|
2024
Q1 | $360K | Sell |
4,223
-412
| -9% | -$35.1K | ﹤0.01% | 1460 |
|
|
2023
Q4 | $396K | Sell |
4,635
-53
| -1% | -$4.53K | ﹤0.01% | 1459 |
|
|
2023
Q3 | $420K | Buy |
4,688
+148
| +3% | +$13.3K | ﹤0.01% | 1336 |
|
|
2023
Q2 | $387K | Buy |
4,540
+358
| +9% | +$30.5K | ﹤0.01% | 1358 |
|
|
2023
Q1 | $346K | Buy |
4,182
+319
| +8% | +$26.4K | ﹤0.01% | 1425 |
|
|
2022
Q4 | $304K | Sell |
3,863
-1,106
| -22% | -$87K | ﹤0.01% | 1493 |
|
|
2022
Q3 | $368K | Sell |
4,969
-98
| -2% | -$7.26K | ﹤0.01% | 1296 |
|
|
2022
Q2 | $330K | Buy |
+5,067
| New | +$330K | ﹤0.01% | 1378 |
|
|
2021
Q3 | – | Sell |
-4,781
| Closed | -$319K | – | 1776 |
|
|
2021
Q2 | $319K | Sell |
4,781
-1,136
| -19% | -$75.8K | ﹤0.01% | 1357 |
|
|
2021
Q1 | $657K | Buy |
+5,917
| New | +$657K | 0.01% | 954 |
|